Results

• All
• Video
• Audio
• Images

• Most recent
• Filter by category

1–2 of 2 results for senolytic

• 

  Senolytic Candidate UBX1325 for Diabetic Macular Edema: The BEHOLD Phase 2 and ASPIRE Phase 2b Trials

  Dante Joseph Pieramici, MD

  Annual Meeting Talks

  2025

• 

  ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD

  Raj K. Maturi, MD

  Annual Meeting Talks

  2023